Stephen Cornelissen on 20th Strategic Blood Forum from Australian Red Cross Lifeblood
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”It was wonderful to come together this week with global and local experts from government, clinical practice, industry, and the community for the 20th Strategic Blood Forum, hosted by Australian Red Cross Lifeblood.
The Forum provided a valuable opportunity to share knowledge and explore global trends in blood product supply, demand, policy, and innovation and consider their relevance to Australia. At Lifeblood, we are committed to driving meaningful change for the health and wellbeing of Australians today, tomorrow and well into the future.
A special thank you to our ambassador Michael Klim for sharing his insights as a recipient of the plasma derived product IVIg, along with his partner Michelle who also presented.
Demand is growing for this product, and we are grateful for all our plasma donors.”
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results
-
Oct 27, 2026, 11:42Cece Calhoun: ASH Promotes Clinical Research Training and Mentorship for Emerging Hematologists
-
Oct 27, 2026, 11:41Ifeanyichukwu Ifechidere: The Laboratory Challenges of Measuring Direct Factor Xa Inhibitors
-
Oct 27, 2026, 11:39Gene Therapy Offers New Possibilities for Patients with Thalassaemia in the UAE – Thalassaemia International Federation
-
Oct 27, 2026, 11:35Alan Nurden: rFVIIa Prophylaxis May Reduce Bleeding-Related Healthcare Burden in Glanzmann Thrombasthenia
-
Oct 27, 2026, 10:12Cesar Garrido: WFH Connects with Spanish Thrombosis and Haematology Societies
-
Oct 27, 2026, 10:01Chokri Ben Lamine: CAPS After Autologous SCT – Diagnostic Criteria and Key Mimics